CRBP has been in the news 375% more than usual
Sep 10, 2024, 10:34 PM
-67.10%
What does CRBP do
Corbus Pharmaceuticals, based in Norwood, Massachusetts, focuses on developing therapies for rare inflammatory diseases and cancer, with a pipeline including CRB-701 and CRB-601. The company went public on October 24, 2014, and employs 19 staff.
CRBP has been in the news recently: BridgeBio Oncology Therapeutics (BBOT) has appointed Dr. Yong (Ben) Ben as Chief Medical and Development Officer. He will oversee clinical programs and the development of therapies including BBO-8520, BBO-10203, and BBO-11818.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
